The HepQuant Lab has moved a short distance within the Fitzsimons Innovation Community Campus to Bioscience 1, located at 12635 E. Montview Blvd., Suite 175, Aurora, CO 80045.
The new lab space is adjacent to our previous location where we’ve been for the past five years, according to HepQuant Chief Scientific Officer Steve Helmke, Ph.D. “The new lab had an ideal configuration to support our state-of-the-art LC-MS assays, as well as space for offices for employees. Bioscience 1 has additional conferencing facilities for client meetings.
The specialized laboratory and office spaces that make up the 97,000 square feet of Bioscience 1 is home to more than 50 companies.
“We are excited to move into a facility that will better support our growing business and laboratory needs,” said Chief Executive Officer and HepQuant test inventor Dr. Greg Everson. “The new facility will enhance the continued growth of client programs, including liver testing support services to liver research centers and pharmaceutical companies.”
In late summer 2022, the HepQuant laboratory achieved COLA accreditation for laboratory quality assurance. COLA is a third-party accreditation organization that ensures labs comply with federal regulations, including those set by Clinical Laboratory Improvement Amendments (CLIA), the governing body that sets regulations for all clinical laboratories in the United States. “This certification means that our lab is ready to begin processing patient samples once FDA approval is obtained,” Everson added.